Showing 1 - 20 results of 48 for search 'Koleka Mlisana', query time: 0.06s Refine Results
  1. 1
    The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus

    The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus by Sharana Mahomed, Sujith Basanth, Koleka Mlisana

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Resazurin microtitre plate assay and Sensititre® MycoTB for detection of Mycobacterium tuberculosis resistance in a high tuberculosis resistance setting

    Resazurin microtitre plate assay and Sensititre® MycoTB for detection of Mycobacterium tuberculosis resistance in a high tuberculosis resistance setting by Prenika Jaglal, Melendhran Pillay, Koleka Mlisana

    Published 2019-12-01
    Get full text
    Article
  3. 3
    Where are we going with HIV vaccines?

    Where are we going with HIV vaccines? by Lynn Morris, Carolyn Williamson, Koleka Mlisana, Glenda Gray

    Published 2010-01-01
    Get full text
    Article
  4. 4
    Where are we going with HIV vaccines?

    Where are we going with HIV vaccines? by Lynn Morris, Carolyn Williamson, Koleka Mlisana, Glenda Gray

    Published 2010-01-01
    Get full text
    Article
  5. 5
    Where are we going with HIV vaccines?

    Where are we going with HIV vaccines? by Lynn Morris, Carolyn Williamson, Koleka Mlisana, Glenda Gray

    Published 2010-01-01
    Get full text
    Article
  6. 6
    Where are we going with HIV vaccines?

    Where are we going with HIV vaccines? by Lynn Morris, Carolyn Williamson, Koleka Mlisana, Glenda Gray

    Published 2010-01-01
    Get full text
    Article
  7. 7
    Where are we going with HIV vaccines?

    Where are we going with HIV vaccines? by Lynn Morris, Carolyn Williamson, Koleka Mlisana, Glenda Gray

    Published 2010-01-01
    Get full text
    Article
  8. 8
    Where are we going with HIV vaccines?

    Where are we going with HIV vaccines? by Lynn Morris, Carolyn Williamson, Koleka Mlisana, Glenda Gray

    Published 2010-01-01
    Get full text
    Article
  9. 9
    Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: Impact on bedside clinical decision making

    Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal: Impact on bedside clinical decision making by Sharana Mahomed, Koleka Mlisana, Lindiwe Cele, Kogieleum Naidoo

    Published 2020-08-01
    Get full text
    Article
  10. 10
    Where are we going with HIV vaccines?

    Where are we going with HIV vaccines? by Lynn Morris, Carolyn Williamson, Koleka Mlisana, Glenda Gray

    Published 2010-01-01
    Get full text
    Article
  11. 11
    Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis

    Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis by Koleka Mlisana, Nomonde Ritta Mvelase, Yusentha Balakrishna, Keeren Lutchminarain

    Published 2019-11-01
    Get full text
    Article
  12. 12
    Failure of BACTEC™ MGIT 960™ to detect <i>Mycobacterium tuberculosis </i> complex within a 42-day incubation period

    Failure of BACTEC™ MGIT 960™ to detect <i>Mycobacterium tuberculosis </i> complex within a 42-day incubation period by Sharana Mahomed, Nomonde R. Dlamini-Mvelase, Moses Dlamini, Koleka Mlisana

    Published 2017-04-01
    Get full text
    Article
  13. 13
    Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.

    Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region. by Yacoob Mahomed Coovadia, Sharana Mahomed, Melendhran Pillay, Lise Werner, Koleka Mlisana

    Published 2013-01-01
    Get full text
    Article
  14. 14
    High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.

    High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa. by Abraham J Niehaus, Koleka Mlisana, Neel R Gandhi, Barun Mathema, James C M Brust

    Published 2015-01-01
    Get full text
    Article
  15. 15
    The fall-And rise-In hospital-based care for people with HIV in South Africa: 2004-2017.

    The fall-And rise-In hospital-based care for people with HIV in South Africa: 2004-2017. by Evelyn Lauren, Khumbo Shumba, Matthew P Fox, William MacLeod, Wendy Stevens, Koleka Mlisana, Jacob Bor, Dorina Onoya

    Published 2024-01-01
    Get full text
    Article
  16. 16
    Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis

    Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginos... by Anna-Ursula Happel, Ravesh Singh, Nireshni Mitchev, Koleka Mlisana, Heather B. Jaspan, Shaun L. Barnabas, Jo-Ann S. Passmore

    Published 2020-07-01
    Get full text
    Article
  17. 17
    Monitoring for advanced disease in the universal test and treat era: trends in CD4 count testing in South Africa

    Monitoring for advanced disease in the universal test and treat era: trends in CD4 count testing in South Africa by Cornelius Nattey, Dorina Onoya, Khumbo Shumba, Dickman Gareta, William Macleod, Matthew P. Fox, Adrian Puren, Koleka Mlisana, Jacob Bor

    Published 2025-01-01
    Get full text
    Article
  18. 18
    Enrolling adolescents in research on HIV and other sensitive issues: lessons from South Africa.

    Enrolling adolescents in research on HIV and other sensitive issues: lessons from South Africa. by Jerome Amir Singh, Salim S Abdool Karim, Quarraisha Abdool Karim, Koleka Mlisana, Carolyn Williamson, Clive Gray, Michelle Govender, Andrew Gray

    Published 2006-07-01
    Get full text
    Article
  19. 19
    HIV prevention in high-risk women in South Africa: condom use and the need for change.

    HIV prevention in high-risk women in South Africa: condom use and the need for change. by Francois van Loggerenberg, Alexis A Dieter, Magdalena E Sobieszczyk, Lise Werner, Anneke Grobler, Koleka Mlisana, CAPRISA 002 Acute Infection Study Team

    Published 2012-01-01
    Get full text
    Article
  20. 20
    High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa

    High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa by Nokukhanya Msomi, Kogieleum Naidoo, Nonhlanhla Yende-Zuma, Nesri Padayatchi, Kerusha Govender, Jerome Amir Singh, Salim Abdool-Karim, Quarraisha Abdool-Karim, Koleka Mlisana

    Published 2020-11-01
    Get full text
    Article

Search Tools: